Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Share this content:
Sponsor and Collaborators

Vejle Hospital
Abbott

Contact
Anders Jakobsen, MD, DMSc
anders.jakobsen@slb.regionsyddanmark.dk

Hanne Kanstrup, MD
hanne.kanstrup@slb.regionsyddanmark.dk

Principal Investigator
Hanne Kanstrup, MD
Vejle Hospital

ClinicalTrials.gov Identifier
NCT01690598

Loading links....

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs